Retatrutide 10 mg — Advanced Triple-Agonist Research Peptide

Retatrutide is a next-generation investigational peptide designed for advanced metabolic and obesity research. Its unique triple-agonist mechanism targets GLP-1, GIP, and glucagon receptors—key regulators of appetite, energy balance, and metabolic function.

Why Researchers Choose Retatrutide

✔ Triple-pathway metabolic engagement✔ Studied for appetite signaling and satiety pathways✔ Investigated for energy expenditure and fat metabolism✔ Supports advanced obesity and metabolic research models

Product Specifications

• Form: Lyophilized powder

• Purity: ≥99%

• Quantity: 10 mg

• Intended Use: Research purposes only

Commitment to Quality

Each vial is produced under strict quality standards to ensure purity, stability, and consistency for research applications.